Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny M Ho

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncoimmunology|March 26, 2013
Targeting SIRPα in cancerJenny M Ho, Jayne S Danska, Jean C Y Wang
JCI Insight|September 22, 2017
Emerging therapies for acute myeloid leukemia: translating biology into the clinicSimon Kavanagh, Tracy Murphy, Arjun Law, et al.
Infection and Immunity|April 20, 2016
CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In VivoKodjo Ayi, Ziyue Lu, Lena Serghides, et al.
Blood Advances|November 4, 2020
CD200 expression marks leukemia stem cells in human AMLJenny M Ho, Stephanie M Dobson, Veronique Voisin, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Journal of General Internal Medicine|November 30, 2022
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) StudyBenjamin Chin-Yee, Pratibha Bhai, Ian Cheong, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or <i>SF3B1</i> Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart ReviewShamim Mortuza, Benjamin Chin-Yee, Tyler E James, et al.
The Journal of Experimental Medicine|September 5, 2012
Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenograftsAlexandre P A Theocharides, Liqing Jin, Po-Yan Cheng, et al.
Leukemia|February 6, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group StudyJames T England, Natasha Szuber, Shireen Sirhan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncoimmunology|March 26, 2013
Targeting SIRPα in cancerJenny M Ho, Jayne S Danska, Jean C Y Wang
JCI Insight|September 22, 2017
Emerging therapies for acute myeloid leukemia: translating biology into the clinicSimon Kavanagh, Tracy Murphy, Arjun Law, et al.
Infection and Immunity|April 20, 2016
CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In VivoKodjo Ayi, Ziyue Lu, Lena Serghides, et al.
Blood Advances|November 4, 2020
CD200 expression marks leukemia stem cells in human AMLJenny M Ho, Stephanie M Dobson, Veronique Voisin, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Journal of General Internal Medicine|November 30, 2022
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) StudyBenjamin Chin-Yee, Pratibha Bhai, Ian Cheong, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or <i>SF3B1</i> Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart ReviewShamim Mortuza, Benjamin Chin-Yee, Tyler E James, et al.
The Journal of Experimental Medicine|September 5, 2012
Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenograftsAlexandre P A Theocharides, Liqing Jin, Po-Yan Cheng, et al.
Leukemia|February 6, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group StudyJames T England, Natasha Szuber, Shireen Sirhan, et al.
Pageof 1